Hybrid Event

WEHI Spatial Technology Symposium

Melbourne & online

Register Now

June 6-7

Melbourne & online Hybrid event

Free registration

Conference infomation

The WEHI Spatial Technology Symposium will showcase the latest innovations in this rapidly evolving field and feature scientific talks from leading scientists as well as early career researchers. This hybrid event can be attended in-person or viewed online.

Take this opportunity to know more about Lunaphore’s universal, end-to-end spatial biology solution, answering the needs of the scientific community from early discovery to late-stage translational and clinical research.

Lunaphore will contribute to the scientific programme with a talk.
For info, registration and agenda please click here.

Lunaphore Presentation

June 6th

June 6th

June 6 - 6:10 AM (Switzerland), 2:10 PM (Singapore), 4:10 PM (Melbourne)

Wehi Institute or ONLINE

Spatial biology methods have shed light on the complexity of the tissue architecture, revealing common and rare cell types and their intercellular interactions in a spatial context. 

Here, we will show you how to generate reproducible spatial data with COMET™, a universal hyperplex solution for high-throughput spatial multiomics.  

We will present how to explore the cellular microenvironment from basic to translational research in the field of immune-oncology and beyond. We will also highlight our new fully automated, spatial multiomics workflow that integrates the simultaneous detection of RNA, with RNAscope™ HiPlex, and protein, with sequential immunofluorescence (seqIF™), on the same tissue section at the single-cell level.  

In addition, Dr. Joe Yeong will focus on the interactions between tumor and neighboring immune cells within the tumor microenvironment. He will demonstrate the use of COMET™ to stain 40 markers on various cancer tissues using off-the-shelf, non-conjugated primary antibodies. 


Joe Yeong, MBBS, PhD, Mmed (Pathology)

Joe Yeong, MBBS, PhD, Mmed (Pathology)

Group Leader

Institute of Molecular and Cell Biology, A*STAR, Singapore | Department of Anatomical Pathology, Singapore General Hospital

Dr. Joe Yeong’s main research focus is to understand and overcome the resistance of immunecheckpoint blockade immunotherapy. As an immuno-pathologist, his key vision is to bridge between immunologists and pathologists to better harness the advances of immunotherapy and further beyond. He is the pioneer in automation of quantitative multiplex immunohistochemistry, using clinical autostainers to study and quantitate tumour immune microenvironment in clinical samples, and has published > 100 papers in this field. His works on cancer immunology are included in multiple National Medical Research Council funded studies as well as pharmaceutical industry sponsored projects (>13 million dollars since 2017). He also served as a committee member in the World Immunotherapy Council, Society for Immunotherapy of Cancer (SITC) and is one of the organizers for its 2019 WIC Global Symposium as well as multiplex IF expert consensus meeting 2022. He also serves as Program Chair of one of the largest AI medical Imaging conferences, CLINICCAI-MICCAI. He is also a board member of Elsevier (Immunoinformatics), SLAS Technology (Journal), Frontiers and Pathogens. He serves as a Secretary (Executive) in Singapore Society of Oncology – Cancer Immunotherapy Consortium, Co-lead in Education/Diagnostic of Singhealth Duke-NUS Cell Therapy Centre as well as Advisor (Spatial Technology), Cancer Discovery Hub, National Cancer Centre.
Andreas Wiesner, Ph.D.

Andreas Wiesner, Ph.D.

Head of Product Management

Lunaphore Technologies, a Bio-Techne brand

Dr. Andreas Wiesner is Head of Product Management for Lunaphore Technologies, a Bio-Techne brand. He obtained his Ph.D. in Neurobiology at the ETH Zürich, Switzerland and conducted research in proteomics of Alzheimer’s Disease at the Brain and Mind Research Institute of the University of New South Wales in Sydney, Australia. During his 15 years in Product Management, he covered various industries, including research, biopharma, and CAR-T cell manufacturing, and led the commercialization of many products in cell culture, microfluidics, and proteomics. He joined Lunaphore Technologies in 2021 and, together with his team, has built Lunaphore’s product portfolio consisting of the hyperplex, immunofluorescence platform COMET™ for automated staining and imaging, SPYRE™ antibodies and Panel Builder for modular and instant mIF protocols, and HORIZON™, the specialized mIF tissue analysis software making Spatial Biology analysis intuitive even for beginners.